Comparison of SGA Oral Medications and a Long-Acting Injectable SGA: The PROACTIVE Study-Reference-Cited by-同舟云学术

Comparison of SGA Oral Medications and a Long-Acting Injectable SGA: The PROACTIVE Study

Published:2014-05-27 Issue:2 Volume:41 Page:449-459
ISSN:1745-1701
Container-title:Schizophrenia Bulletin
language:en
Short-container-title:

Author:

Buckley Peter F.¹,Schooler Nina R.²³,Goff Donald C.⁴,Hsiao John⁵,Kopelowicz Alexander⁶,Lauriello John⁷,Manschreck Theo⁸,Mendelowitz Alan J.³,Miller Del D.⁹,Severe Joanne B.⁵,Wilson Daniel R.¹⁰,Ames Donna⁶,Bustillo Juan¹¹,Mintz Jim¹²,Kane John M.³,

Affiliation:

1. Medical College of Georgia , Georgia Regents University , Augusta , GA ;

2. Downstate Medical Center , State University of New York , Brooklyn , NY ;

3. Feinstein Institute for Medical Research , Zucker Hillside Hospital , Glen Oaks , NY ;

4. Nathan Kline Institute , Orangeburg , NY ;

5. National Institute of Mental Health , Bethesda , MD ;

6. David Geffen School of Medicine , University of California at Los Angeles , Los Angeles, CA ;

7. Columbia School of Medicine , University of Missouri , Columbia , MO ;

8. Harvard Medical School , Corrigan MH Center , Beth Israel Deaconess Medical Center , Boston , MA ;

9. Department of Psychiatry Research , University of Iowa Carver College of Medicine , Iowa City , IA ;

10. Department of Anthropology , The University of Florida College of Medicine at Jacksonville , Jacksonville , FL ;

11. Department of Psychiatry , University of New Mexico School of Medicine , Albuquerque , NM ;

12. Health Science Center , University of Texas , San Antonio , TX

Publisher

Oxford University Press (OUP)

Subject

Psychiatry and Mental health

Link

http://academic.oup.com/schizophreniabulletin/article-pdf/41/2/449/16704327/sbu067.pdf

Reference38 articles.

1. Schizophrenia, “just the facts” 5. Treatment and prevention. Past, present, and future;Tandon;Schizophr Res,2010

2. Relapse prevention and recovery in the treatment of schizophrenia;Schooler;J Clin Psychiatry,2006

3. Past and present progress in the pharmacologic treatment of schizophrenia;Kane;J Clin Psychiatry,2010

4. Non-adherence to medication in patients with psychotic disorders: epidemiology, contributing factors and management strategies;Kane;World Psychiatry,2013

5. Oral versus depot antipsychotic drugs for schizophrenia–a critical systematic review and meta-analysis of randomised long-term trials;Leucht;Schizophr Res,2011

Cited by 59 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. All-cause mortality risk in long-acting injectable versus oral antipsychotics in schizophrenia: a systematic review and meta-analysis;Molecular Psychiatry;2024-08-22

2. Long-Acting Injectable Antipsychotics—A Review on Formulation and In Vitro Dissolution;Pharmaceutics;2023-12-24

3. Can multisite clinical trial results change clinical practice? Use of long-acting injectable risperidone nationally in the Veterans Health Administration;Trials;2023-02-06

4. Longitudinal study of inflammation and relapse in schizophrenia;Schizophrenia Research;2023-02

5. Weight changes in people with early psychosis treated with oral or long-acting injectable aripiprazole;Schizophrenia Research;2023-01